![]() |
|
|
South Dakota State University, Brookings, SD 57007 and * Wichita State University, Wichita, KS 67260
2To whom correspondence should be addressed. E-mail: matthew_vukovich{at}sdstate.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: older adults humans exercise training body composition ß-hydroxy-ß-methylbutyrate (HMB)
| INTRODUCTION |
|---|
|
|
|---|
The factor that seems to be most effective in maintaining body
muscle is engaging in regular resistance exercise training. Resistance
training in older adults is a viable means of maintaining body muscle
mass. It has been shown to result in gains in strength
(40200%) and increases in fat-free mass (4.811%)
(2
3
4)
. However, only a fraction of the elderly population
is actively involved in progressive resistance training. The
process is slow, time consuming and may ultimately cause a greater
amount of muscle damage and exercise-induced proteolysis
(5)
. Clearly, a strategy must be found that would increase
the effectiveness of exercise.
One strategy to increase the effectiveness of exercise in the elderly
is to attempt to attenuate the exercise-related increase in muscle
protein turnover with nutrition. This should result in greater gains
per unit of exercise and could lessen the training time and/or
intensity. The leucine metabolite ß-hydroxy-ß-methylbutyrate
(HMB)3
would seem a likely candidate in that it
has been shown to decrease muscle proteolysis and muscle damage and
increase fat-free mass gain in young adults undergoing resistance
training (6
7
8)
.
The purpose of the current study was to determine whether dietary HMB supplementation in 70-y-old adults participating in a modest 5 d/wk exercise program would result in greater gains in fat-free mass and strength as well as greater losses in fat mass compared with an age- and fitness-matched group consuming a placebo.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Thirty-two individuals (16 men and 16 women, mean age 70 ± 1 y) volunteered for this study and signed an informed consent in accordance with the Human Subjects Committee of Wichita State University. Subjects participating in the study had no contraindications to exercise, were taking no medications and had their physicians approval to participate. Potential subjects were excluded from participating if they had uncontrolled hypertension, a history of cardiovascular disease, diabetes or kidney problems. Before the initiation of the study, subjects had no experience with resistance training.
Study design.
Subjects were randomly assigned to one of two groups. Group A received 3 g/d of the leucine metabolite ß-hydroxy-ß-methylbutyrate (HMB), Group B received 3 g/d of a placebo (rice flour). Both treatments were administered in a double-blind fashion. Capsules were identical in size and appearance. Each HMB capsule contained 250 mg of Ca (HMB)2 · H2O and 50 mg of potassium phosphate (monobasic, KH2PO4). Subjects were supplied with 10 d worth of supplement at a time. Bottles were labeled with the subjects name and identification number. When subjects reported for the next bottle or testing, they were asked about compliance. All reported compliance. Subjects consumed 4 capsules, 3 times per day for a total of 12 capsules/d. Diets were not controlled.
Strength testing.
The subjects reported to the gym for instruction on use of the exercise
equipment. Four training sessions were used to familiarize the subjects
with the equipment and proper lifting techniques. Testing procedures
were standardized on the basis of specific seat adjustments and body
positions according to manufacturers instructions. Upper and lower
body strength was assessed before, at wk 4 and after the 8 wk of
training with a one-repetition maximum (1-RM) test. The 1-RM test
was defined as the maximal resistance that could be moved through the
full range of motion for one repetition. Subjects were allowed five
warm-up repetitions before testing and were allowed
60 s of rest
between trials. They completed the same number of trials (average
34) before and after training to reach the 1-RM. Strength
measurements were completed on the overhead press, bench press,
latissimus pull down, elbow extension and flexion, double leg flexion,
double leg extension and leg press.
Exercise program.
The exercise program consisted of the above eight lifts using Badger Fitness Equipment (variable resistance machines; Magnum Fitness Systems, South Milwaukee, WI). Each subject trained two nonconsecutive days per week for 8 wk. Subjects completed two sets of 1012 repetitions. Intensity began at 70% of the 1-RM. Every 2 wk, another 1-RM test was performed and the individuals resistance was changed accordingly. On the other 3 d per week, the subjects reported to an indoor track (6 laps/mile; 3.7 laps/km) for a combination walking and stretching program. Each walking session consisted of 10 min of warm-up and stretching, 40 min of self-paced walking, and 10 min of cool-down and stretching. Four exercise specialists supervised the training sessions. Subjects were required to make up any missed training sessions and subjects complied with the instructions.
Blood collection/analysis.
Blood samples were collected from a superficial vein into Vacutainer blood tubes (Vacutainer Systems, Rutherford, NJ) after an overnight fast before supplementation and after 8 wk of training/supplementation. Blood samples were processed and analyzed for plasma HMB levels to ensure compliance.
Skin fold.
Skin fold thickness measurements were obtained before and after 4
and 8 wk of training. Skin fold measurements were taken from the
subscapular, triceps, biceps, midaxillary, pectoral (men only),
suprailiac, umbilical and front thigh. The percentage of
body fat was estimated by using the equations of Jackson and Pollock
(9)
.
Computerized tomography (CT scan).
CT scans of the right thigh and upper arm were made before the study
began and immediately after the 8 wk. The CT measurements were made in
a subset of subjects (n = 20). The CT scan was
performed at these sites, which corresponded to the skin fold
measurements (9)
. To ensure reproducibility, a great deal
of care was placed on consistently landmarking and measuring the
position of the CT scans. The measurement for the upper arm was made at
a point halfway between the acromion and olecranon processes, with the
elbow extended and relaxed. The measurement on the thigh was made at a
point midway between the greater trochanter and the lateral condyle of
the femur. The volunteers (placebo, n = 11; HMB,
n = 9) were examined in the supine position. A
pillow was placed underneath the shoulder, hips and calf to prevent the
muscles from compressing. The scanner was a Picker PQ 2000 (Marconi
Medical Systems, Cleveland, OH) operating at 130 kV peak;
slices were 8 mm wide, with a scan time of 2 s, at 150 mA with a
field size of 30. Images were scanned using a Hewlett-Packard 4P
scanner (Palo Alto, CA). The surface area (pixels) of the fat and
muscle regions were measured on the basis of image density using Sigma
Scan Pro (SPSS, Chicago, IL).
Dual X-ray absorptiometry (DXA).
A total body scan was performed using DXA (model DPX-L, LUNAR Radiation, Madison, WI) and analyzed using the LUNAR Radiation body composition program. Fat mass, lean mass and bone mineral content were determined for the total body and for arm, leg and trunk regions. Statistically, 68% of repeat scans fall within 1 SD. DXA measurements were made before the initiation of the study and immediately after the 8 wk. The measurements were made in a subset of subjects (n = 23: placebo, n = 12; HMB, n = 11).
Statistical design.
Absolute and relative changes in strength and body composition were calculated and analyzed by SAS General Linear Model (GLM) procedures (SAS Institute, Cary, NC). The effect of gender and the gender x treatment interaction were not significant and data were pooled; the differences between the two treatment (placebo vs. HMB) effects are presented. The 4- and 8-wk treatment changes in strength and body composition were analyzed by one-way ANOVA. In addition, the effect of treatment by time on body composition measured at 0, 4 and 8 wk was analyzed as a repeated-measures ANOVA. All data are reported as means ± SEM. Significant difference was set at P < 0.05; a tendency to differ was set at P < 0.10.
| RESULTS |
|---|
|
|
|---|
Body composition.
During the 8-wk training period, subjects weight was unaltered
by training and supplementation (Table 1
). However, skin fold analysis showed changes in the percentage of body
fat and an alteration in fat-free mass by the combination of
resistance training and supplementation. A repeated-measures ANOVA
(time) from 0 to 8 wk indicated that HMB supplementation tended to
increase fat-free mass gain (P = 0.08; Table 1
,
Fig. 1
). Furthermore, HMB supplementation significantly decreased the
percentage of body fat compared with the placebo group (Fig. 2A
). DXA scans on a subset of subjects showed a similar net difference in
the percentage of body fat (P = 0.32; Fig. 2A
)
and increase in fat-free mass.
|
|
|
The area of muscle in the thigh increased to the same extent in both
groups during the 8 wk of training [HMB, 2020.7 ± 1052.9
pixels (4.6 ± 2.2%); placebo, 1767.9 ± 793.0 pixels
(4.4 ± 2.1%)]. However, there was a significant reduction in
the area of fat for the HMB group [-9172.1 ± 2461.2 pixels
(-22.3 ± 4.3%)], whereas the placebo group significantly
increased the area of fat for the thigh [5169.9 ± 2090.7 (15.5
± 5.5%)]. Furthermore, CT scan analysis showed that the HMB
supplementation significantly decreased the percentage of fat (pixel
area of fat/pixel areas of fat and muscle) for total arm and thigh as
well as the thigh alone compared with placebo supplementation (Fig. 2B
).
Strength.
Upper-body strength was assessed using five different exercises and summing the one repetition maximum (1RM) for each lift to obtain total upper body strength [nonsignificant (P = 0.99) 8-wk % change; HMB, 14.9 ± 2.0%; placebo, 14.9 ± 2.9%]. The relative increase in strength in the latissimus pull down after 4 wk of treatment was significantly greater in the HMB group (11.5 ± 3.5%) compared with the placebo group (1.5 ± 3.2%). Lower body strength was assessed using three different exercises and summing the 1RM for each lift to obtain total lower body strength [nonsignificant (P = 0.45) 8-wk % change; HMB, 21.8 ± 3.6%; placebo, 18.1 ± 3.4%]. There was a significant difference in the absolute and relative increase in strength between the two groups in the leg curl after wk 4 and 8. For the other exercises, there were no significant differences in strength between the two groups or over time. However, the relative increase in total lower body strength after 4 wk of treatment approached significance (P = 0.08), 7.4 and 12.8% for placebo and HMB groups, respectively.
| DISCUSSION |
|---|
|
|
|---|
The percentage of increase in fat-free mass seen in this study is
consistent with the increase due to HMB supplementation in previous
studies of young adults (Fig. 3
). Data from six studies have been (6
7
8
,10)
or will be
published concerning HMB supplementation in humans. For the
HMB-supplemented group, these studies show a greater increase in
the percentage of fat-free mass gained from resistance training
compared with the placebo-supplemented subjects. However, HMB
supplementation alone, without resistance training, does not affect
body composition (11)
. The findings from the current study
suggest that 70-y-old adults respond to HMB supplementation with an
increase in fat-free mass from resistance training that is similar
to that reported in young adults.
|
11 and 13% for the upper body and 7 and 13% for the lower
body for the placebo and HMB groups, respectively. The increase in
strength is lower than that reported by others (up to a 40% increase)
(2
The safety of HMB was also measured in this study, but the results are
reported elsewhere (16)
. As is the case in young adults,
HMB does not appear to have any adverse effects in 70-y-old adults.
Although the definitive mechanism of HMB has not been proven,
previously reported decreases in protein breakdown [decreased
3-methylhistidine and creatine phosphokinase activity
(6
,8)
], decreases in in vitro proteolysis in rats and
chicks (17)
, and decreases in muscle calpain and cathespin
proteolytic activities in rats (18)
all suggest that HMB
acts by decreasing muscle proteolysis. The decrease in muscle
proteolysis combined with the stimulus of resistance training could
then result in greater rates of net muscle protein deposition.
In conclusion, HMB supplementation alters body composition during an 8-wk exercise program in 70-y-old adults in a manner similar to its effect in young adults. This suggests that the underlying mechanism causing the stimulation of fat-free mass gain by HMB is essentially independent of age.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
3 Abbreviations used: CT, computerized tomography; DXA, dual X-ray absorptiometry; HMB, ß-hydroxy-ß-methylbutyrate; 1-RM, one-repetition maximum. ![]()
Manuscript received September 11, 2000. Revision accepted April 19, 2001.
| REFERENCES |
|---|
|
|
|---|
1. Rogers M. A., Evans W. J. Changes in skeletal muscle with aging: effects of exercise training. Exerc. Sport Sci. Rev. 1993;21:65-102[Medline]
2.
Treuth M. S., Ryan A. S., Pratley R. E., Rubin M. A., Miller J. P., Nicklas B. J., Sorkin J., Harman S. M., Goldberg A. P., Hurley B. F. Effects of strength training on total and regional body composition in older men [published erratum appears in J. Appl. Physiol. 77 following table of contents]. J. Appl. Physiol. 1994;77:614-620
3.
Frontera W. R., Meredith C. N., OReilly K. P., Knuttgen H. G., Evans W. J. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J. Appl. Physiol. 1988;64:1038-1044
4. Hurley B. F., Redmond R. A., Pratley R. E., Treuth M. S., Rogers M. A., Goldberg A. P. Effects of strength training on muscle hypertrophy and muscle cell disruption in older men. Int. J. Sports Med. 1995;16:378-384[Medline]
5.
Fielding R. A., Meredith C. N., OReilly K. P., Frontera W. R., Cannon J. G., Evans W. J. Enhanced protein breakdown after eccentric exercise in young and older men. J. Appl. Physiol. 1991;71:674-679
6.
Nissen S., Sharp R., Ray M., Rathmacher J. A., Rice J., Fuller J. C., Jr, Connelly A. S., Abumrad N. N. The effect of the leucine metabolite ß-hydroxy-ß-methylbutyrate on muscle metabolism during resistance-exercise training. J. Appl. Physiol. 1996;81:2095-2104
7. Panton L. B., Rathmacher J. A., Baier S., Nissen S. Nutritional supplementation of the leucine metabolite ß-hydroxy-ß-methylbutyrate (HMB) during resistance training. Nutrition 2000;16:734-739[Medline]
8. Gallagher P. M., Carrithers J. A., Godard M. P., Schulze K. E., Trappe S. W. ß-Hydroxy-ß-methylbutyrate ingestion, Part I: effects on strength and fat free mass. Med. Sci. Sports Exerc. 2000;32:2109-2115[Medline]
9. Jackson A. S., Pollock M. L. Practical assessment of body composition. Physician Sportsmed 1985;13:76-89
10. Kreider R. B., Ferreira M., Wilson M., Almada A. L. Effects of calcium ß-hydroxy-ß-methylbutyrate (HMB) supplementation during resistance-training on markers of catabolism, body composition and strength. Int. J. Sports Med. 1999;20:503-509[Medline]
11. Nissen S. L., Abumrad N. N. Nutritional role of the leucine metabolite ß-hydroxy-ß-methylbutyrate (HMB). J. Nutr. Biochem. 1997;8:300-311
12.
Fiatarone M. A., Marks E. C., Ryan N. D., Meredith C. N., Lipsitz L. A., Evans W. J. High-intensity strength training in nonagenarians. Effects on skeletal muscle. J. Am. Med. Assoc. 1990;263:3029-3034
13.
Miller J. P., Pratley R. E., Goldberg A. P., Gordon P., Rubin M., Treuth M. S., Ryan A. S., Hurley B. F. Strength training increases insulin action in healthy 50- to 65-yr-old men. J. Appl. Physiol. 1994;77:1122-1127
14. Nicklas B. J., Ryan A. J., Treuth M. M., Harman S. M., Blackman M. R., Hurley B. F., Rogers M. A. Testosterone, growth hormone and IGF-I responses to acute and chronic resistive exercise in men aged 5570 years. Int. J. Sports Med. 1995;16:445-450[Medline]
15.
Pratley R., Nicklas B., Rubin M., Miller J., Smith A., Smith M., Hurley B., Goldberg A. Strength training increases resting metabolic rate and norepinephrine levels in healthy 50- to 65-yr-old men. J. Appl. Physiol. 1994;76:133-137
16.
Nissen S., Panton L., Sharp R. L., Vukovich M., Trappe S. W., Fuller J. C. Jr ß-Hydroxy-ß-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J. Nutr. 2000;130:1937-1945
17. Ostaszewski, P., Kostiuk, S., Balasinska, B., Jank, M., Papet, I. & Glomot, F. (2000) The leucine metabolite 3-hydroxy-3-methylbutyrate (HMB) modifies protein turnover in muscles of the laboratory rats and domestic chickens in vitro. J. Anim. Physiol. Anim. Nutr. (in press).
18. Jank M., Ostaszewski P., Rosochacki S., Wilczak J., Balasinska B. Effect of 3-hydroxy-3-methylbutyrate (HMB) on muscle cathepsins and calpain activities during the post-dexamethasone recovery period in young rats. Pol. J. Vet. Sci. 2001;3:213-218
This article has been cited by other articles:
![]() |
H. L. Eley, S. T. Russell, and M. J. Tisdale Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-{alpha} and angiotensin II by {beta}-hydroxy-{beta}-methylbutyrate Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1417 - E1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. McCarty and K. I. Block Toward a Core Nutraceutical Program for Cancer Management Integr Cancer Ther, June 1, 2006; 5(2): 150 - 171. [Abstract] [PDF] |
||||
![]() |
S. L. Nissen and R. L. Sharp Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis J Appl Physiol, February 1, 2003; 94(2): 651 - 659. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||